Michael Petusky
Stock Analyst at Barrington Research
(2.04)
# 2,795
Out of 4,829 analysts
195
Total ratings
35.29%
Success rate
-7.86%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $20 → $21 | $15.82 | +32.74% | 21 | May 12, 2025 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $20 → $19 | $11.64 | +63.23% | 17 | May 12, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $90 → $86 | $68.64 | +25.29% | 14 | May 6, 2025 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 | $1.24 | +81.45% | 14 | May 1, 2025 | |
| OPCH Option Care Health | Maintains: Outperform | $38 | $31.84 | +19.35% | 15 | Apr 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $103 | $95.83 | +7.48% | 20 | Apr 25, 2025 | |
| VRME VerifyMe | Maintains: Outperform | $1.5 → $1.25 | $0.77 | +63.40% | 9 | Mar 7, 2025 | |
| MODV ModivCare | Maintains: Outperform | $10 → $6 | $1.17 | +412.82% | 14 | Mar 7, 2025 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $108 → $98 | $74.07 | +32.31% | 22 | Feb 28, 2025 | |
| LMAT LeMaitre Vascular | Downgrades: Market Perform | n/a | $80.26 | - | 9 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $95 | $68.19 | +39.32% | 28 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.97 | - | 6 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $26.91 | - | 6 | May 30, 2024 |
DENTSPLY SIRONA
May 12, 2025
Maintains: Outperform
Price Target: $20 → $21
Current: $15.82
Upside: +32.74%
Anika Therapeutics
May 12, 2025
Maintains: Outperform
Price Target: $20 → $19
Current: $11.64
Upside: +63.23%
Henry Schein
May 6, 2025
Maintains: Outperform
Price Target: $90 → $86
Current: $68.64
Upside: +25.29%
OPKO Health
May 1, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.24
Upside: +81.45%
Option Care Health
Apr 30, 2025
Maintains: Outperform
Price Target: $38
Current: $31.84
Upside: +19.35%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $103
Current: $95.83
Upside: +7.48%
VerifyMe
Mar 7, 2025
Maintains: Outperform
Price Target: $1.5 → $1.25
Current: $0.77
Upside: +63.40%
ModivCare
Mar 7, 2025
Maintains: Outperform
Price Target: $10 → $6
Current: $1.17
Upside: +412.82%
U.S. Physical Therapy
Feb 28, 2025
Maintains: Outperform
Price Target: $108 → $98
Current: $74.07
Upside: +32.31%
LeMaitre Vascular
Feb 28, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $80.26
Upside: -
Feb 7, 2025
Maintains: Outperform
Price Target: $108 → $95
Current: $68.19
Upside: +39.32%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $6.97
Upside: -
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $26.91
Upside: -